|
UC Irvine Healthcare’s Ablative Oncology Center offers the latest and least invasive treatments to ablate—or destroy—lung cancer and pleural disease. Through the center, patients have access to the expertise and care provided by our highly skilled team of surgeons, interventional radiologists, nurses, technicians and other medical professionals at UC Irvine Medical Center.
Among the conditions our ablative cardiothoracic specialists treat are:Radiofrequency ablation (RFA) is the most frequently used ablative treatment for primary lung cancer for patients who are not candidates for surgical resection because they lack adequate pulmonary reserves or have major medical comorbid conditions. An experienced team of interventional radiologists and thoracic surgeons working together first locate the tumor precisely with advanced imaging technology such as a computed tomography (CT) or a magnetic resonance imaging (MRI) scanner. A probe is then inserted into the tumor to deliver radiofrequency heat to destroy the cancer cells with minimal effect on surrounding tissue. Patients who undergo RFA ablation often can go home the same day or after a brief overnight stay to ensure there are no complications.
The center's specialists also perform minimally invasive radiofrequency or microwave ablation of metastatic lung lesions that are no amenable to standard surgical or radiation therapy. Another area of intense investigation and clinical application at UC Irvine is in the use of cryoablation to destroy malignant mesothelioma or other pleural tumors, combined with standard surgical debulking procedures.
Other cardiothoracic ablative services
Cardiac arrhythmia has long been treated ablatively by electrophysiology cardiologists and cardiac surgeons who deliver electrical impulses to treat atrial tachyarrhythmias, including atrial fibrillation and atrial flutter. At UC Irvine Medical Center, we also use state-of-the-art minimally invasive thoracoscopic and robot-assisted techniques to perform RFA ablation to cure paroxysmal and persistent atrial fibrillation with a success rate of greater than 80 percent.
For more information or to make an appointment to see a UC Irvine Healthcare ablative lung, pleural or heart specialist, please call 714-456-3634.
Jeffrey Milliken, MD Cardiothoracic surgeon |
|
|